protein tyrosine phosphatase 1B inhibitors (Affymax)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprotein tyrosine phosphatase 1B inhibitors (Affymax)
Drug Alias NamePTPase1B inhibitors (Affymax)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffymax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffymax Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A